vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Alexandria Real Estate Equities (ARE). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $671.0M, roughly 1.5× Alexandria Real Estate Equities). Alexandria Real Estate Equities runs the higher net margin — 59.4% vs -1.1%, a 60.5% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs -11.5%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs -6.4%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9...

ALHC vs ARE — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.5× larger
ALHC
$1.0B
$671.0M
ARE
Growing faster (revenue YoY)
ALHC
ALHC
+55.9% gap
ALHC
44.4%
-11.5%
ARE
Higher net margin
ARE
ARE
60.5% more per $
ARE
59.4%
-1.1%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
-6.4%
ARE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALHC
ALHC
ARE
ARE
Revenue
$1.0B
$671.0M
Net Profit
$-11.0M
$398.4M
Gross Margin
Operating Margin
-1.0%
Net Margin
-1.1%
59.4%
Revenue YoY
44.4%
-11.5%
Net Profit YoY
64.6%
740.6%
EPS (diluted)
$-0.04
$2.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ARE
ARE
Q1 26
$671.0M
Q4 25
$1.0B
$754.4M
Q3 25
$993.7M
$751.9M
Q2 25
$1.0B
$762.0M
Q1 25
$926.9M
$758.2M
Q4 24
$701.2M
$788.9M
Q3 24
$692.4M
$791.6M
Q2 24
$681.3M
$766.7M
Net Profit
ALHC
ALHC
ARE
ARE
Q1 26
$398.4M
Q4 25
$-11.0M
$-1.1B
Q3 25
$3.7M
$-232.8M
Q2 25
$15.7M
$-107.0M
Q1 25
$-9.1M
$-8.9M
Q4 24
$-31.1M
$-62.2M
Q3 24
$-26.4M
$167.9M
Q2 24
$-24.0M
$46.7M
Operating Margin
ALHC
ALHC
ARE
ARE
Q1 26
Q4 25
-1.0%
Q3 25
0.8%
Q2 25
2.2%
Q1 25
-0.6%
Q4 24
-3.2%
Q3 24
-2.8%
Q2 24
-2.7%
Net Margin
ALHC
ALHC
ARE
ARE
Q1 26
59.4%
Q4 25
-1.1%
-143.3%
Q3 25
0.4%
-31.0%
Q2 25
1.5%
-14.0%
Q1 25
-1.0%
-1.2%
Q4 24
-4.4%
-7.9%
Q3 24
-3.8%
21.2%
Q2 24
-3.5%
6.1%
EPS (diluted)
ALHC
ALHC
ARE
ARE
Q1 26
$2.10
Q4 25
$-0.04
$-6.35
Q3 25
$0.02
$-1.38
Q2 25
$0.07
$-0.64
Q1 25
$-0.05
$-0.07
Q4 24
$-0.15
$-0.38
Q3 24
$-0.14
$0.96
Q2 24
$-0.13
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ARE
ARE
Cash + ST InvestmentsLiquidity on hand
$604.2M
$418.7M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$19.4B
Total Assets
$1.1B
$34.2B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ARE
ARE
Q1 26
$418.7M
Q4 25
$604.2M
$549.1M
Q3 25
$644.1M
$579.5M
Q2 25
$503.8M
$520.5M
Q1 25
$479.5M
$476.4M
Q4 24
$470.6M
$552.1M
Q3 24
$381.0M
$562.6M
Q2 24
$363.7M
$561.0M
Total Debt
ALHC
ALHC
ARE
ARE
Q1 26
Q4 25
$323.2M
$12.4B
Q3 25
$322.7M
$13.6B
Q2 25
$322.3M
$13.3B
Q1 25
$321.9M
$13.1B
Q4 24
$321.4M
$12.2B
Q3 24
$212.0M
$12.7B
Q2 24
$211.7M
$12.4B
Stockholders' Equity
ALHC
ALHC
ARE
ARE
Q1 26
$19.4B
Q4 25
$179.3M
$15.5B
Q3 25
$161.9M
$16.6B
Q2 25
$141.0M
$17.2B
Q1 25
$108.1M
$17.5B
Q4 24
$99.9M
$17.9B
Q3 24
$114.5M
$18.2B
Q2 24
$123.7M
$18.3B
Total Assets
ALHC
ALHC
ARE
ARE
Q1 26
$34.2B
Q4 25
$1.1B
$34.1B
Q3 25
$1.1B
$37.4B
Q2 25
$1.0B
$37.6B
Q1 25
$895.6M
$37.6B
Q4 24
$782.1M
$37.5B
Q3 24
$692.3M
$38.5B
Q2 24
$716.3M
$37.8B
Debt / Equity
ALHC
ALHC
ARE
ARE
Q1 26
Q4 25
1.80×
0.80×
Q3 25
1.99×
0.82×
Q2 25
2.29×
0.77×
Q1 25
2.98×
0.75×
Q4 24
3.22×
0.68×
Q3 24
1.85×
0.70×
Q2 24
1.71×
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ARE
ARE
Operating Cash FlowLast quarter
$-50.4M
$475.0M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
76.0%
Cash ConversionOCF / Net Profit
1.19×
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ARE
ARE
Q1 26
$475.0M
Q4 25
$-50.4M
$312.4M
Q3 25
$144.6M
$433.5M
Q2 25
$29.1M
$460.2M
Q1 25
$16.6M
$207.9M
Q4 24
$-8.7M
$274.2M
Q3 24
$26.2M
$477.4M
Q2 24
$23.5M
$411.8M
Free Cash Flow
ALHC
ALHC
ARE
ARE
Q1 26
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
FCF Margin
ALHC
ALHC
ARE
ARE
Q1 26
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Capex Intensity
ALHC
ALHC
ARE
ARE
Q1 26
76.0%
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Cash Conversion
ALHC
ALHC
ARE
ARE
Q1 26
1.19×
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
2.84×
Q2 24
8.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

ARE
ARE

Same properties$431.4M64%
Tenant recoveries$178.2M27%
Non-same properties$43.3M6%
Other$18.0M3%

Related Comparisons